Follow
Zhongqiu Xie
Zhongqiu Xie
Verified email at virginia.edu
Title
Cited by
Cited by
Year
Recurrent chimeric fusion RNAs in non-cancer tissues and cells
M Babiceanu, F Qin, Z Xie, Y Jia, K Lopez, N Janus, L Facemire, S Kumar, ...
Nucleic acids research 44 (6), 2859-72, 2016
1742016
Foxm1 transcription factor is required for maintenance of pluripotency of P19 embryonal carcinoma cells
Z Xie, G Tan, M Ding, D Dong, T Chen, X Meng, X Huang, Y Tan
Nucleic acids research 38 (22), 8027-8038, 2010
1102010
Intergenically spliced chimeric RNAs in cancer
Y Jia, Z Xie, H Li
Trends in cancer 2 (9), 475-484, 2016
852016
A chimeric RNA characteristic of rhabdomyosarcoma in normal myogenesis process
H Yuan, F Qin, M Movassagh, H Park, W Golden, Z Xie, P Zhang, J Sklar, ...
Cancer discovery 3 (12), 1394-1403, 2013
762013
A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma
Xie Z, Janczyk PŁ, Zhang Y, Liu A, Shi X, Singh S, Facemire L, Kubow K, Li Z ...
Nature Communications 11 (1), 3457, 2020
442020
Fusion transcriptome profiling provides insights into alveolar rhabdomyosarcoma
Z Xie, M Babiceanu, S Kumar, Y Jia, F Qin, FG Barr, H Li
Proceedings of the National Academy of Sciences 113 (46), 13126-13131, 2016
362016
Superlocalization spectral imaging microscopy of a multicolor quantum dot complex
X Shi, Z Xie, Y Song, Y Tan, ES Yeung, H Gai
Analytical chemistry 84 (3), 1504-1509, 2012
332012
Increased levels of FoxA1 transcription factor in pluripotent P19 embryonal carcinoma cells stimulate neural differentiation
Y Tan, Z Xie, M Ding, Z Wang, Q Yu, L Meng, H Zhu, X Huang, L Yu, ...
Stem cells and development 19 (9), 1365-1374, 2010
322010
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
Q Wang, Z Li, J Yang, S Peng, Q Zhou, K Yao, W Cai, Z Xie, F Qin, H Li, ...
Cancer biology & medicine 19 (8), 1193, 2022
202022
Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition
Shu Z, Li Z, Huang H, Chen Y, Fan J, Yu L, Wu Z, Tian L, Qi Q, Peng S, Wei C ...
Oncogene, https://doi.org/10.1038/s41388-020-01403, 2020
19*2020
Landscape characterization of chimeric RNAs in colorectal cancer
H Wu, S Singh, Z Xie, X Li, H Li
Cancer letters 489, 56-65, 2020
162020
PAX3-FOXO1 escapes miR-495 regulation during muscle differentiation
Z Xie, Y Tang, X Su, J Cao, Y Zhang, H Li
RNA Biology 16 (1), 144–153, 2019
152019
Fas-associated factor 1 inhibits tumor growth by suppressing Helicobacter pylori-induced activation of NF-κB signaling in human gastric carcinoma
Ai-qun Liu, Zhongqiu Xie, Xiao-ni Chen, Jie Feng, Jia-wei Chen, Fu-jun Qin ...
Oncotarget 8 (5), 7999-8009, 2016
14*2016
GADD45B Is a Potential Diagnostic and Therapeutic Target Gene in Chemotherapy-Resistant Prostate Cancer
Qiong Wang, Wanhua Wu, Ze Gao, Kaiwen Li, Shirong Peng, Huiyang Fan ...
Frontiers in cell and developmental biology, 2021
122021
Profile of chimeric RNAs and TMPRSS2-ERG e2e4 isoform in neuroendocrine prostate cancer
Q Wang, J Chen, S Singh, Z Xie, F Qin, X Shi, R Cornelison, H Li, ...
Cell & Bioscience 12 (1), 153, 2022
92022
CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment
J Li, T Huang, J Hua, Q Wang, Y Su, P Chen, S Bidlingmaier, A Li, Z Xie, ...
Journal of Experimental & Clinical Cancer Research 42 (1), 61, 2023
82023
Functional heritage: the evolution of chimeric RNA into a gene.
H Wu, S Singh, X Shi, Z Xie, E Lin, X Li, H Li
RNA Biology 17 (1), doi: 10.1080/15476286.2019.1670038., 2019
82019
上皮间质转化与肿瘤干细胞在化疗耐药中作用的研究进展
任华益, 曾勇, 谢仲秋, 尹继业, 张为家
肿瘤药学 2 (1), 7-9, 2012
62012
A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3
Q Wang, B Cheng, S Singh, Y Tao, Z Xie, F Qin, X Shi, J Xu, C Hu, W Tan, ...
NPJ Precision Oncology 8 (11), 2024
52024
Coordination Mechanism of Closed-Loop Supply Chain with Retailer as Leader under Asymmetric Information
G Peng, X Zhong-qiu, X Yin-cheng
Industrial Engineering Journal 16 (1), 79, 2013
42013
The system can't perform the operation now. Try again later.
Articles 1–20